Medtronic’s Cardiac Disease Management Offerings Seek To Grow HF Market
This article was originally published in The Gray Sheet
Executive Summary
Medtronic believes that its foray into cardiac disease management with the Chronicle implantable hemodynamic monitor will differentiate its devices from competitors Guidant and St. Jude